-
1
-
-
34250758914
-
Radioimmunotherapy as a Therapeutic Option for Non-Hodgkin's Lymphoma
-
DOI 10.1016/j.semradonc.2007.02.003, PII S1053429607000148, Lymphoma
-
RM Macklis 2007 Radioimmunotherapy as a therapeutic option for non-Hodgkin's lymphoma Semin Radiat Oncol 17 176 183 10.1016/j.semradonc.2007. 02.003 17591564 (Pubitemid 46963028)
-
(2007)
Seminars in Radiation Oncology
, vol.17
, Issue.3
, pp. 176-183
-
-
Macklis, R.M.1
-
2
-
-
33645149340
-
Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
-
10.1007/s10238-006-0087-6 1:CAS:528:DC%2BD28XislWksb8%3D 16550338
-
RO Dillman 2006 Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies Clin Exp Med 6 1 12 10.1007/s10238-006-0087-6 1:CAS:528:DC%2BD28XislWksb8%3D 16550338
-
(2006)
Clin Exp Med
, vol.6
, pp. 1-12
-
-
Dillman, R.O.1
-
3
-
-
34249725061
-
131 tositumomab
-
DOI 10.1038/sj.onc.1210378, PII 1210378
-
131 tositumomab Oncogene 26 3614 3628 10.1038/sj.onc.1210378 1:CAS:528:DC%2BD2sXlslCqsbk%3D 17530015 (Pubitemid 46842712)
-
(2007)
Oncogene
, vol.26
, Issue.25
, pp. 3614-3628
-
-
Davies, A.J.1
-
6
-
-
33847334389
-
186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model
-
1:CAS:528:DC%2BD2sXhvFKmtr8%3D 17204708
-
186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model J Nucl Med 48 122 127 1:CAS:528:DC%2BD2sXhvFKmtr8%3D 17204708
-
(2007)
J Nucl Med
, vol.48
, pp. 122-127
-
-
Ogawa, K.1
Mukai, T.2
Asano, D.3
Kawashima, H.4
Kinuya, S.5
Shiba, K.6
-
7
-
-
46849118098
-
188Re-pharmaceuticals
-
10.1016/j.addr.2008.04.008 1:CAS:528:DC%2BD1cXoslWktro%3D 18547675
-
188Re-pharmaceuticals Adv Drug Deliv Rev 60 1389 1401 10.1016/j.addr.2008.04.008 1:CAS:528:DC%2BD1cXoslWktro%3D 18547675
-
(2008)
Adv Drug Deliv Rev
, vol.60
, pp. 1389-1401
-
-
Ferro-Flores, G.1
Arteaga De Murphy, C.2
-
8
-
-
1842408972
-
Availability of rhenium-188 from the alumina-based tungsten-188/rhenium- 188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment
-
1:CAS:528:DyaK2sXktVCms7o%3D 9179235
-
FF Knapp Jr AL Beets S Guhlke PO Zamora H Bender H Palmedo, et al. 1997 Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment Anticancer Res 17 1783 1795 1:CAS:528:DyaK2sXktVCms7o%3D 9179235
-
(1997)
Anticancer Res
, vol.17
, pp. 1783-1795
-
-
Knapp Jr, F.F.1
Beets, A.L.2
Guhlke, S.3
Zamora, P.O.4
Bender, H.5
Palmedo, H.6
-
10
-
-
0025940111
-
Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: Labeling and animal biodistribution studies
-
1:CAS:528:DyaK3MXlslyhu74%3D 1873804
-
GL Griffiths DM Goldenberg FF Knapp Jr AP Callahan CH Chang HJ Hansen 1991 Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies Cancer Res 51 4594 4602 1:CAS:528:DyaK3MXlslyhu74%3D 1873804
-
(1991)
Cancer Res
, vol.51
, pp. 4594-4602
-
-
Griffiths, G.L.1
Goldenberg, D.M.2
Knapp Jr, F.F.3
Callahan, A.P.4
Chang, C.H.5
Hansen, H.J.6
-
11
-
-
22644446717
-
Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals
-
DOI 10.1021/bc040249w
-
K Ogawa T Mukai Y Arano M Ono H Hanaoka S Ishino, et al. 2005 Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals Bioconjug Chem 16 751 757 10.1021/bc040249w 1:CAS:528:DC%2BD2MXls1Ogt78%3D 16029015 (Pubitemid 41026160)
-
(2005)
Bioconjugate Chemistry
, vol.16
, Issue.4
, pp. 751-757
-
-
Ogawa, K.1
Mukai, T.2
Arano, Y.3
Ono, M.4
Hanaoka, H.5
Ishino, S.6
Hashimoto, K.7
Nishimura, H.8
Saji, H.9
-
12
-
-
0031687325
-
Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: In vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice
-
1:CAS:528:DyaK1cXlslGrurY%3D 9765625
-
S Kinuya K Yokoyama H Tega T Hiramatsu S Konishi W Yamamoto, et al. 1998 Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice Jpn J Cancer Res 89 870 878 1:CAS:528:DyaK1cXlslGrurY%3D 9765625
-
(1998)
Jpn J Cancer Res
, vol.89
, pp. 870-878
-
-
Kinuya, S.1
Yokoyama, K.2
Tega, H.3
Hiramatsu, T.4
Konishi, S.5
Yamamoto, W.6
-
14
-
-
0027427836
-
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: A technical protocol
-
1:CAS:528:DyaK2cXktVCjurg%3D 8229241
-
GW Visser M Gerretsen JD Herscheid GB Snow G van Dongen 1993 Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol J Nucl Med 34 1953 1963 1:CAS:528:DyaK2cXktVCjurg%3D 8229241
-
(1993)
J Nucl Med
, vol.34
, pp. 1953-1963
-
-
Visser, G.W.1
Gerretsen, M.2
Herscheid, J.D.3
Snow, G.B.4
Van Dongen, G.5
-
15
-
-
33646547897
-
Rhemium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliation
-
DOI 10.1016/j.nucmedbio.2006.03.006, PII S096980510600062X
-
K Ogawa T Mukai Y Arano A Otaka M Ueda T Uehara, et al. 2006 Rhenium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliation Nucl Med Biol 33 513 520 10.1016/j.nucmedbio.2006.03.006 1:CAS:528:DC%2BD28XkvVOktL0%3D 16720243 (Pubitemid 43729852)
-
(2006)
Nuclear Medicine and Biology
, vol.33
, Issue.4
, pp. 513-520
-
-
Ogawa, K.1
Mukai, T.2
Arano, Y.3
Otaka, A.4
Ueda, M.5
Uehara, T.6
Magata, Y.7
Hashimoto, K.8
Saji, H.9
-
17
-
-
0022449883
-
A monoclonal antibody against human colon cancers
-
10.1620/tjem.148.353 1:STN:280:DyaL283ptVelug%3D%3D 3526636
-
H Kotanagi T Takahashi T Masuko Y Hashimoto K Koyama 1986 A monoclonal antibody against human colon cancers Tohoku J Exp Med 148 353 360 10.1620/tjem.148.353 1:STN:280:DyaL283ptVelug%3D%3D 3526636
-
(1986)
Tohoku J Exp Med
, vol.148
, pp. 353-360
-
-
Kotanagi, H.1
Takahashi, T.2
Masuko, T.3
Hashimoto, Y.4
Koyama, K.5
-
18
-
-
0026128681
-
Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. in vivo comparisons with chloramine-T-labeled Fab
-
10.1021/bc00008a006 1:CAS:528:DyaK3MXhvVWnsLw%3D 1868113
-
DS Wilbur SW Hadley LM Grant MD Hylarides 1991 Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab Bioconjug Chem 2 111 116 10.1021/bc00008a006 1:CAS:528:DyaK3MXhvVWnsLw%3D 1868113
-
(1991)
Bioconjug Chem
, vol.2
, pp. 111-116
-
-
Wilbur, D.S.1
Hadley, S.W.2
Grant, L.M.3
Hylarides, M.D.4
-
19
-
-
2942675512
-
188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation
-
DOI 10.1097/01.mnm.0000130237.91573.34
-
188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation Nucl Med Commun 25 731 736 10.1097/01.mnm.0000130237.91573.34 1:CAS:528:DC%2BD2cXltVSqtrk%3D 15208502 (Pubitemid 38901692)
-
(2004)
Nuclear Medicine Communications
, vol.25
, Issue.7
, pp. 731-736
-
-
He, J.1
Liu, C.2
Vanderheyden, J.-L.3
Liu, G.4
Dou, S.5
Rusckowski, M.6
Hnatowich, D.J.7
-
20
-
-
0036071851
-
+ and synthesis of tailor-made bifunctional ligand systems
-
DOI 10.1021/bc015568r
-
+ and synthesis of tailor-made bifunctional ligand systems Bioconjug Chem 13 750 756 10.1021/bc015568r 1:CAS:528:DC%2BD38XjsFSksrw%3D 12121130 (Pubitemid 34801117)
-
(2002)
Bioconjugate Chemistry
, vol.13
, Issue.4
, pp. 750-756
-
-
Schibli, R.1
Schwarzbach, R.2
Alberto, R.3
Ortner, K.4
Schmalle, H.5
Dumas, C.6
Egli, A.7
Schubiger, P.A.8
-
21
-
-
0036740090
-
Development of annexin v mutants suitable for labeling with Tc(i)-carbonyl complex
-
10.1021/bc025545s 1:CAS:528:DC%2BD38XmtFSrsrY%3D 12236794
-
JF Tait C Smith DF Gibson 2002 Development of annexin V mutants suitable for labeling with Tc(i)-carbonyl complex Bioconjug Chem 13 1119 1123 10.1021/bc025545s 1:CAS:528:DC%2BD38XmtFSrsrY%3D 12236794
-
(2002)
Bioconjug Chem
, vol.13
, pp. 1119-1123
-
-
Tait, J.F.1
Smith, C.2
Gibson, D.F.3
-
22
-
-
31544478028
-
+ for the labeling of biomolecules
-
DOI 10.1021/bc050192t
-
+ for the labeling of biomolecules Bioconjug Chem 17 223 225 10.1021/bc050192t 1:CAS:528:DC%2BD2MXhtlSlu7rF 16417272 (Pubitemid 43157604)
-
(2006)
Bioconjugate Chemistry
, vol.17
, Issue.1
, pp. 223-225
-
-
Park, S.H.1
Seifert, S.2
Pietzsch, H.-J.3
-
23
-
-
67349263521
-
188Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer
-
10.1016/j.nucmedbio.2009.01.006 1:CAS:528:DC%2BD1MXlslWisLY%3D 19423002
-
188Re(I)- tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer Nucl Med Biol 36 355 361 10.1016/j.nucmedbio.2009.01.006 1:CAS:528: DC%2BD1MXlslWisLY%3D 19423002
-
(2009)
Nucl Med Biol
, vol.36
, pp. 355-361
-
-
Chen, K.T.1
Lee, T.W.2
Lo, J.M.3
-
24
-
-
0033968961
-
188re-perrhenate in endovascular irradiation using liquid-filled balloon to prevent restenosis
-
DOI 10.1016/S0969-8051(99)00079-7, PII S0969805199000797
-
188Re- perrhenate in endovascular irradiation using liquid-filled balloon to prevent restenosis Nucl Med Biol 27 83 87 10.1016/S0969-8051(99)00079-7 1:STN:280:DC%2BD3c3hs1ChtA%3D%3D 10755650 (Pubitemid 30099619)
-
(2000)
Nuclear Medicine and Biology
, vol.27
, Issue.1
, pp. 83-87
-
-
Lin, W.-Y.1
Hsieh, J.-F.2
Tsai, S.-C.3
Yen, T.-C.4
Wang, S.J.5
Knapp Jr., F.F.6
-
26
-
-
4043111337
-
177Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin
-
1:CAS:528:DC%2BD2cXnsFygsb0%3D 15235070
-
177Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin J Nucl Med 45 1224 1232 1:CAS:528: DC%2BD2cXnsFygsb0%3D 15235070
-
(2004)
J Nucl Med
, vol.45
, pp. 1224-1232
-
-
Koppe, M.J.1
Bleichrodt, R.P.2
Soede, A.C.3
Verhofstad, A.A.4
Goldenberg, D.M.5
Oyen, W.J.6
-
28
-
-
24644461181
-
Current status of cancer therapy with radiolabeled monoclonal antibody
-
10.1007/BF03027399 1:CAS:528:DC%2BD2MXhtFyhs7nF 16164191
-
N Oriuchi T Higuchi H Hanaoka Y Iida K Endo 2005 Current status of cancer therapy with radiolabeled monoclonal antibody Ann Nucl Med 19 355 365 10.1007/BF03027399 1:CAS:528:DC%2BD2MXhtFyhs7nF 16164191
-
(2005)
Ann Nucl Med
, vol.19
, pp. 355-365
-
-
Oriuchi, N.1
Higuchi, T.2
Hanaoka, H.3
Iida, Y.4
Endo, K.5
|